I just cornered dr Underberg after the lecture. Had a fascinating conversation. I told him I was at the AHA and was amazed by the results. He said “everyone was”. He the said “ I can’t believe the vitriol that came out after the results were presented online and on blogs” I know all the authors personally and felt horrible about the treatment they received. They are excellent researchers. People were treating this LIKE A FAKE MOON LANDING!
Concerning the MO issue “I feel it was well explained by Bhatt and is a “non issue”
He said he would prescribe only per RI population for now and is awaiting fda approval as he thinks insurers won’t cover it. - Disappointing
I asked about the possibility of inclusion in interim lipid guidelines. He said unlikely until new guidelines in 4-5 years BUT he expects AHA and lipid organizations STATEMENTS much sooner and these would be powerful min terms of determining the Standard of Care
Hope this is helpful coming from a lipid thought leader. Only one opinion but my take is medical community is on board that insurance coverage is key and that interim statements and fda approval will be important
News 
Market Data 
Discover 
